Fas antigen and sporadic alzheimer's disease in Southern Italy: Evaluation of two polymorphisms in the TNFRSF6 gene

Neurochemical Research

Volumn 32, Issue 9, 2007, Pages 1445-1449

  Andreoli, Virginia ^a   Nicoletti, Giuseppe ^a   Romeo, Nelide ^a   Condino, Francesca ^a   La Russa, Antonella ^a   Liguori, Maria ^a   Manna, Ida ^a   Spadafora, Patrizia ^a   Quattrone, Aldo ^a,b   Cittadella, Rita ^a  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Alzheimer's disease; Apoptosis; Association study; FAS Polymorphisms; Genetic susceptibility

Indexed keywords

FAS ANTIGEN;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION GENETIC PARAMETERS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; ANTIGENS, CD95; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34447650841     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9329-6     Document Type: Article

References (24)

1. Goate A, Chartier-Harlin MC, Mullan M, Brown J et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349(6311):704-706
2. Sherrington R, Rogaev EI, Liang Y et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375(6534):754-706
3. Levy-Lahad E, Wasco W, Poorkaj P et al (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269(5226):973-977
4. Pericak-Vance MA, Haines JL (1995) Genetic susceptibility to Alzheimer disease. Trends Genet 11:504-508
5. Strittmatter WJ, Saunders AM, Schmechel D et al (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90(5):1977-1981
6. Tanzi RE, Bertram L (2001) New frontiers in Alzheimer's disease genetics. Neuron 32:181-184
7. Smale G, Nichols NR, Brady DR et al (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133(2):225-230
8. Ashkenazi A, Dixit VM (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11(2):255-260
9. Martinez M, Fernandez-Vivancos E, Frank A et al (2000) Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer's disease. Relationship with IL-6 concentrations. Brain Res 869(1-2):216-219
10. Nishimura T, Akiyama H, Yonehara S et al (1995) Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 695(2):137-145
11. Bertram L, Blacker D, Mullin K et al (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290(5500):2302-2303
12. Myers A, Holmans P, Marshall H et al (2000) Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290(5500):2304-2305
13. Feuk L, Prince JA, Breen G et al (2000) Apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene. Hum Genet 107(4):391-396
14. Huang QR, Morris D, Manolios N (1997) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol 34(8-9):577-582
15. Tsukada J, Waterman WR, Koyama Y et al (1996) A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene. Mol Cell Biol 16(5):2183-2194
16. Mc Khann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7):939-944
17. Crum RM, Anthony JC, Bassett SS et al (1993) Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269(18):2386-2391
18. Pericak-Vance MA, Bebout JL, Gaskell PC et al (1991) Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J HumGenet 48(6):1034-1050
19. Chiappelli M, Nasi M, Cossarizza A et al (2006) Polymorphisms of fas gene: relationship with Alzheimer's disease and cognitive decline. Dement Geriatr Cogn Disord 22(4):296-300
20. Huang QR, Danis V, Lassere M et al (1999) Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatology 38(7):645-651
21. Lee YH, Kim YR, Ji JD et al (2001) Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus. J Rheumatol 28(9):2008-2011
22. Cascino I, Ballerini C, Audino S et al (1998) Fas gene polymorphisms are not associated with systemic lupus erythematosus, multiple sclerosis and HIV infection. Dis Markers 13(4):221-225
23. Rosenmann H, Meiner Z, Kahana E et al (2004) The Fas promoter polymorphism at position -670 is not associated with late-onset sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 17(3):143-146
24. He XM, Zhang ZX, Zhang JW et al (2006) The Fas gene A-670G polymorphism is not associated with sporadic Alzheimer disease in a Chinese Han population. Brain Res 1082(1):192-195